5/20/2008

The consumer genome service 23andMe said it will work with Parkinson's disease researchers to collect key patient information through a virtual "field study." The company's co-founder said, "We hope to establish an entirely new paradigm for how genetic research is conducted that actively involves the patient."

Related Summaries